Cargando…

Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with methadone treatment

INTRODUCTION: More than 2 million individuals in the USA have an opioid use disorder (OUD). Methadone maintenance treatment is the gold standard of medication-based treatment for OUD, but high-dose methadone is associated with cardiotoxicity and respiratory complications, among other side effects. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Belcher, Annabelle M, Cole, Thomas O, Greenblatt, Aaron D, Hoag, Stephen W, Epstein, David H, Wagner, Michael, Billing, Amy S, Massey, Ebonie, Hamilton, Kristen R, Kozak, Zofia K, Welsh, Christopher J, Weintraub, Eric, Wickwire, Emerson M, Wish, Eric D, Kaptchuk, Ted J, Colloca, Luana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Addiction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6596949/ https://www.ncbi.nlm.nih.gov/pubmed/31230007 http://dx.doi.org/10.1136/bmjopen-2018-026604

Ejemplares similares

Effectiveness of Conditioned Open-label Placebo With Methadone in Treatment of Opioid Use Disorder: A Randomized Clinical Trial
por: Belcher, Annabelle M., et al.
Publicado: (2023)

Race-based differences in drug use prior to onset of opioid use disorder
por: Deutsch-Link, Sasha, et al.
Publicado: (2023)

Slow release oral morphine versus methadone for the treatment of opioid use disorder
por: Klimas, Jan, et al.
Publicado: (2019)

Dynamic changes in methadone utilisation for opioid use disorder treatment: a retrospective observational study during the COVID-19 pandemic
por: Kennalley, Amy L, et al.
Publicado: (2023)

Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: a population-based observational study protocol in British Columbia, Canada
por: Piske, Micah, et al.
Publicado: (2020)

Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment
por: Kozak, Zofia, et al.
Publicado: (2023)

Patient experiences of COVID-19-induced changes to methadone treatment in a large community-based opioid treatment program in Baltimore
por: Abidogun, Tolulope M., et al.
Publicado: (2023)

Experience and response to a randomised controlled trial of extended-release injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone for opioid use disorder: protocol for a mixed-methods evaluation
por: Lowry, Natalie, et al.
Publicado: (2022)

The relative risk of fatal poisoning by methadone or buprenorphine within the wider population of England and Wales
por: Marteau, Dave, et al.
Publicado: (2015)

Is the promise of methadone Kenya’s solution to managing HIV and addiction? A mixed-method mathematical modelling and qualitative study
por: Rhodes, Tim, et al.
Publicado: (2015)

Factors associated with nicotine dependence during methadone maintenance treatment: findings from a multisite survey in Vietnam
por: Do, Huyen Phuc, et al.
Publicado: (2017)

Positive percentages of urine morphine tests among methadone maintenance treatment clients with HIV/AIDS: a 12-month follow-up study in Guangdong Province, China
por: Luo, Xiaofeng, et al.
Publicado: (2017)

Evaluating comparative effectiveness of psychosocial interventions for persons receiving opioid agonist therapy for opioid use disorder: protocol for a systematic review
por: Rice, Danielle B, et al.
Publicado: (2018)

Opioid overdose decedent characteristics during COVID-19
por: Garcia, Gian-Gabriel P., et al.
Publicado: (2022)

Primary care management of Long-Term opioid therapy
por: Coffin, Phillip O., et al.
Publicado: (2022)

Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study
por: Larney, Sarah, et al.
Publicado: (2018)

Comparing opioid types in the persistence of opioid use following surgical admission: a study protocol for a retrospective observational linkage study comparing tapentadol and oxycodone in Australia
por: Lam, Tina, et al.
Publicado: (2022)

Randomised, pragmatic, waitlist controlled trial of cannabis added to prescription opioid support on opioid dose reduction and pain in adults with chronic non-cancer pain: study protocol
por: Jashinski, Julia, et al.
Publicado: (2022)

Rewarding recovery: the time is now for contingency management for opioid use disorder
por: Proctor, Steven L.
Publicado: (2022)

Allostatic load in opioid use disorder: a scoping review protocol
por: Fan, Jaimie Qiuyun, et al.
Publicado: (2023)

Epidemiological trends in opioid-only and opioid/polysubstance-related death rates among American Indian/Alaska Native populations from 1999 to 2019: a retrospective longitudinal ecological study
por: Qeadan, Fares, et al.
Publicado: (2022)

Quality of life and relapse of Opioid Use Disorder: a scoping review protocol
por: Namatovu, Angella, et al.
Publicado: (2023)

Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study
por: Liu, Yin, et al.
Publicado: (2017)

Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study
por: Larney, Sarah, et al.
Publicado: (2014)

Barriers and facilitators to buprenorphine use for opioid agonist treatment: protocol for a scoping review
por: Leece, Pamela, et al.
Publicado: (2019)

Contingency management for tobacco smoking during opioid addiction treatment: a randomised pilot study
por: Ainscough, Tom Stephen, et al.
Publicado: (2017)

Opioid use disorder in chronic non-cancer pain in Germany: a cross sectional study
por: Just, Johannes Maximilian, et al.
Publicado: (2019)

Scoping review protocol: the use of telemedicine in providing opioid agonist treatment and related psychosocial supports
por: Crowley, Des, et al.
Publicado: (2020)

U.S. Military veterans and the opioid overdose crisis: a review of risk factors and prevention efforts
por: Bennett, Alex S., et al.
Publicado: (2022)

Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol
por: Peacock, Amy, et al.
Publicado: (2018)

What are the characteristics of vitamin D metabolism in opioid dependence? An exploratory longitudinal study in Australian primary care
por: Reece, Albert Stuart, et al.
Publicado: (2018)

Risk of behaviour suggestive of opioid abuse: a protocol for a systematic review of validated assessment tools
por: Galindo, Sheila Raposo, et al.
Publicado: (2018)

The changing epidemiology of opioid overdose in Baltimore, Maryland, 2012–2017: insights from emergency medical services
por: Dun, Chen, et al.
Publicado: (2022)

Prior authorization restrictions on medications for opioid use disorder: trends in state laws from 2005 to 2019
por: Andraka-Christou, Barbara, et al.
Publicado: (2023)

Interest in treatment with injectable diacetylmorphine among people who use opioids in Baltimore City, Maryland (USA)
por: Allen, Sean T., et al.
Publicado: (2023)

From pain treatment to opioid dependence: a qualitative study of the environmental influence on codeine use in UK adults
por: Kinnaird, Emma, et al.
Publicado: (2019)

Facilitators of and barriers to buprenorphine initiation for people with opioid use disorder in the emergency department: protocol for a scoping review
por: Bozinoff, Nikki, et al.
Publicado: (2021)

Mixed-methods study to examine the response of opioid addiction treatment programmes to COVID-19: a study protocol
por: Choi, Sugy, et al.
Publicado: (2022)

Perceptions of COVID-19 risk during the pandemic: perspectives from people seeking medication for opioid use disorder
por: Clingan, Sarah E., et al.
Publicado: (2023)

Prescription opioid injection and risk of hepatitis C in relation to traditional drugs of misuse in a prospective cohort of street youth
por: Hadland, Scott E, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2ihhr6iok3vuajle9r7ib2nl56